Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

Background: Xpert® MTB/RIF, a rapid tuberculosis (TB) molecular test, was endorsed by the World Health Organization in 2010. Since then, 34.4 million cartridges have been procured under concessional pricing. Although the roll out of this diagnostic is promising, previous studies showed low market pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazabon, Danielle, Pande, Tripti, Kik, Sandra, Van Gemert, Wayne, Sohn, Hojoon, Denkinger, Claudia, Qin, Zhi Zhen, Waning, Brenda, Pai, Madhukar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139378/
https://www.ncbi.nlm.nih.gov/pubmed/30234198
http://dx.doi.org/10.12688/gatesopenres.12842.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139378/
https://www.ncbi.nlm.nih.gov/pubmed/30234198
http://dx.doi.org/10.12688/gatesopenres.12842.2

Ejemplares similares